BODY ADIPOSITY AND ITS RELATIONSHIP OF METABOLIC SYNDROME COMPONENTS IN COLOMBIAN ADULTS

Objective: recently, Bergman et al. have introduced a new index of adiposity, namely, body adiposity index (BAI), as a marker of obesity excess body fat in clinical practice. We aimed to determine the prevalence of obesity and metabolic syndrome (MetS) and to assess the predicting ability of BAI in various atherogenic indices, MetS and its components among adult from Bogota, Colombia. Methods: cross-sectional study in 690 male. MetS components (waist circumference 90 cm; fasting plasma glucose >= 100 mg/dL, blood pressure >= 135/85 mm Hg; triglycerides >= 150 mg/dL and HDL-c <= 40 mg/dL were measured. Atherogenic indices (cholesterol/HDL-c, LDL-c/HDL-c, triglycerides/HDL-c, lipid-metabolic index [LMI] and MetS score) were calculated. Results: the prevalence of obesity by BAI (cut-point > 26.1%) and MetS was 50.1% and 19.1%, respectively. Subjects with MetS and obesity by BAI, show lower HDL-c levels and more frequently components of MetS (waist circumference, cholesterol and serum triglycerides). Predicting ability of BAI with a greater odds for atherogenic indices were 1.78 (95 %CI 1.25 to 2.55), 1.46 (95 %CI 1.01 to 2.14), 1.97 (95% 1.29 to 3.02), 2.04 (95%CI 1.23 to 3.39) and 1.47 (95 %CI 1.03 to 2.11), elevation in LDL-c, LMI, MetS score and cholesterol/HDL-c, and triglyceride/HDL-c, respectively (p <0.05). Conclusion: subjects with higher levels of BAI show raised prevalence of obesity and positively associated with components of MetS.